Literature DB >> 11477661

Chromosomal imbalances in gastric and esophageal adenocarcinoma: specific comparative genomic hybridization-detected abnormalities segregate with junctional adenocarcinomas.

S C Stocks1, N Pratt, M Sales, D A Johnston, A M Thompson, F A Carey, N M Kernohan.   

Abstract

The incidence of adenocarcinoma arising at the esophagogastric junction (EGJ) is increasing at a rate greater than that for any other form of solid malignancy. Commensurate with this, the incidence of histologically similar tumors arising in the gastric body and antral mucosa is declining. The increased incidence of the proximal group of tumors may reflect, in part, the higher prevalence of Barrett esophagus. These epidemiological features suggest that histologically similar tumors arising at the EGJ and from the distal stomach are different, which may be reflected in the genetic abnormalities that characterize the two groups of tumors. The purpose of this study was to screen genomic DNA from adenocarcinomas of the esophagus and stomach for regions of chromosomal imbalance, using comparative genomic hybridization to determine whether tumors at the EGJ (junctional tumors) have a different profile compared with tumors of the distal stomach. Tumor samples were derived from a series of 48 gastroesophageal adenocarcinomas (20 junctional and 28 distal) that were acquired prospectively from patients undergoing esophagogastrectomy. These tumors are characterized by several regions of chromosomal imbalance with no obvious correlation between most regions of abnormal copy number and tumor type. However, our study shows for the first time cytogenetic abnormalities (5p+ and 18q-) that identify statistically significant differences (P < 0.02 and < 0.05, respectively) between junctional and distal gastric tumors. These differences are gain of 5p (55% [11/20] of junctional tumors vs. 21% [6/28] of distal gastric tumors) and loss of 18q (25% [5/20] cases of junctional tumors vs. 4% [1/28] of distal tumors) segregating with tumors of the EGJ. These abnormalities may distinguish distinct tumor subtypes that are recognized in epidemiological and clinical studies but that are otherwise histologically identical. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11477661     DOI: 10.1002/gcc.1166

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

1.  Common genetic variants in epigenetic machinery genes and risk of upper gastrointestinal cancers.

Authors:  Hyuna Sung; Howard H Yang; Han Zhang; Qi Yang; Nan Hu; Ze-Zhong Tang; Hua Su; Lemin Wang; Chaoyu Wang; Ti Ding; Jin-Hu Fan; You-Lin Qiao; William Wheeler; Carol Giffen; Laurie Burdett; Zhaoming Wang; Maxwell P Lee; Stephen J Chanock; Sanford M Dawsey; Neal D Freedman; Christian C Abnet; Alisa M Goldstein; Kai Yu; Philip R Taylor; Paula L Hyland
Journal:  Int J Epidemiol       Date:  2015-04-27       Impact factor: 7.196

2.  Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma.

Authors:  Patrapim Sunpaweravong; Somkiat Sunpaweravong; Puttisak Puttawibul; Winyou Mitarnun; Chan Zeng; Anna E Barón; Wilbur Franklin; Sherif Said; Marileila Varella-Garcia
Journal:  J Cancer Res Clin Oncol       Date:  2004-10-19       Impact factor: 4.553

3.  Recurrent amplification of MYC and TNFRSF11B in 8q24 is associated with poor survival in patients with gastric cancer.

Authors:  Xiaohong Wang; Yiqiang Liu; Duanfang Shao; Ziliang Qian; Zhengwei Dong; Yun Sun; Xiaofang Xing; Xiaojing Cheng; Hong Du; Ying Hu; Yingai Li; Lin Li; Bin Dong; Ziyu Li; Aiwen Wu; Xiaojiang Wu; Zhaode Bu; Xianglong Zong; Guanshan Zhu; Qunsheng Ji; Xian-zi Wen; Lian-hai Zhang; Jia-fu Ji
Journal:  Gastric Cancer       Date:  2015-01-25       Impact factor: 7.370

4.  Genetic variants in fas signaling pathway genes and risk of gastric cancer.

Authors:  Paula L Hyland; Shih-Wen Lin; Nan Hu; Han Zhang; Lemin Wang; Hua Su; Chaoyu Wang; Ti Ding; Ze-Zhong Tang; Jin-Hu Fan; You-Lin Qiao; Xiaoqin Xiong; William Wheeler; Carol Giffen; Kai Yu; Jeff Yuenger; Laurie Burdett; Zhaoming Wang; Stephen J Chanock; Margaret A Tucker; Sanford M Dawsey; Neal D Freedman; Alisa M Goldstein; Christian C Abnet; Philip R Taylor
Journal:  Int J Cancer       Date:  2013-09-11       Impact factor: 7.396

5.  Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach.

Authors:  Y Tajima; K Yamazaki; R Makino; N Nishino; Y Masuda; S Aoki; M Kato; K Morohara; M Kusano
Journal:  Br J Cancer       Date:  2007-01-30       Impact factor: 7.640

6.  Characterization of human gastric adenocarcinoma cell lines established from peritoneal ascites.

Authors:  Bożenna Mytar; Małgorzata Stec; Rafał Szatanek; Kazimierz Węglarczyk; Katarzyna Szewczyk; Antoni Szczepanik; Grażyna Drabik; Jarek Baran; Maciej Siedlar; Monika Baj-Krzyworzeka
Journal:  Oncol Lett       Date:  2018-02-08       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.